INTRODUCTION
Amongst the highest brain functions cognition is a matter of growing interest mainly due to the increasing prevalence of socially signifi cant diseases leading to cognitive decline in adults such as neurodegenerative dementias and cerebrovascular disorders. In addition, multiple sclerosis, an immune-mediated disease of the central nervous system, is associated with a high rate (40-70%) of cognitive impairment. In all these conditions genetic predisposition has been established as one of the important etiological factors. Gene polymorphisms are found in more than 1% of the healthy human population. Single nucleotide polymorphisms (SNPs) -deletions, insertions, substitutions -are the most commonly occurring polymorphisms. Depending on their position in the genome, SNPs can affect the gene expression or the functional activity of the encoded protein.
The combination of inherited and acquired SNPs determines the individual genotypic characteristics of each person, affects phenotypic features and the risk for developing certain diseases.
Cytokine synthesis is under strict genetic control. Cytokine genes are known to be highly polymorphic genes, but primarily within their protein-non-coding, regulatory sequences. Some cytokine SNPs have no clinical signifi cance but many of them are functional, i.e. changing the gene expression and synthesis of the immune protein. Functional SNPs in cytokine genes are regarded as a possible cause for imbalance in the cytokine production, contributing to various pathological conditions. 1 There is a large amount of evidence for participation of immune mechanisms and especially cytokines in neurodevelopment and cognitive functioning in humans. Experimental studies suggest that neurogenesis and synaptic plasticity, which are the cellular mechanisms of cognition, are strongly infl uenced by various cytokines. 2, 3 The cytokine effects on these processes seem to be dependent on their concentrations: under physiological conditions interleukine (IL)-1b has maintained long-term
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The aim of this review is to summarize the contemporary knowledge about the correlations between different genetic variants of SNPs in cytokine genes and cognitive status in humans.
Various SNPs in several cytokine genes have been investigated in relation to cognitive functions. The most studied in this context are polymorphisms in IL-1b, IL-6, IL-10, IL-17A, IL-18 and TNF-alpha genes. The data obtained from this research are highly divergent.
EVIDENCE FOR ASSOCIATION BETWEEN SNPS IN CYTOKINE GENES AND DIFFERENT COGNI-TIVE DOMAINS
Some investigators fi nd association between genetic variants of SNPs and a particular cognitive domain ( Table 1) . Studies of Beste et al. (2010) in young, healthy adults suggest that attentional processes are affected by the TNF-alpha-308 A/G SNP. 12, 13 The A allele has been associated with better attentional processes. The same authors explain these fi ndings with the facilitating effect of TNF-alpha on glutamatergic neural transmission, which has been shown to boost attentional selection processes. Entirely different are the observations of Gadjewski et al. (2013) in elderly people -carriers of A allele of TNF-alpha-308 A/G have shown dysfunction in some aspects of attention. 14 The same allele in the study of Baune et al. (2008) has been associated with better information processing speed. 15 These observations were not confi rmed by other authors. 16 Correlation between SNPs in IL-1b gene and memory functions has also been observed. The CT/ TT genotype of IL-1b-1418C/T (rs16944) has been signifi cantly associated with poorer memory in the participants of MEMO (Memory and Morbidity in Augsburg Elderly) study. 15 In accordance with this are the fi ndings of Tsai et al. (2010) . 17 Signifi cant associations between two other SNPs in IL-1b gene (rs1143634 and rs1143633) and the verbal intelligence quotient have been reported by Sasayama et al. (2011) . 18 A study of Marioni et al. (2010) has implicated IL-1a gene polymorphisms rs2856838 and rs3783654 in mental fl exibility. 19 SNPs (rs554344 and rs580253) in IL-1b-converting enzyme (IL1bCE) gene have been reported to infl uence cytokine production and cognitive functions. Subjects carrying the variants 10643C and 5352A allele in this gene have had signifi cantly lower IL-1b serum levels and homozygous carriers of the same alleles have performed better on all executive function tests in PROSPER (PROspective Study of Pravastatin in the Elderly at Risk) study. In addition, the haplotype with two variants (10643C and 5352A) present has been associated with better executive functions compared to the haplotype without variants. The authors have observed the same trend for memory function. 20 
A ROLE OF CYTOKINE GENE POLYMORPHISMS FOR AGE-RELATED CHANGES IN COGNITION
Studies have found a link between SNPs and both current cognitive status and its change over time ( Table 1) . SNPs related to high pro-infl ammatory or low anti-infl ammatory activity have been revealed as independent risk factors of reduced cognitive function in octogenarians. Subjects homozygous for the IL-18-607G-137C haplotype have shown poorer results on Performance Intellectual Quotient (IQ) subtests of Wechsler Adult Intelligence Scale. The TNF-alpha-308GA genotype has been related to a lower Verbal IQ-score and the IL-10-592 CC genotype has been associated with better Verbal IQ at the age of 80. TNF-308GA heterozygotes have had a more marked decline in Full IQ score from age 80 to age 85 and the same tendency has been observed for Verbal IQ in IL-10-592CC homozygotes. 21 The correlation between four polymorphisms in IL-10 gene and cognition has also been assessed in the participants of PROSPER study. Carriers of the 4259G and -2849A variants performed worse on all cognitive domains. The same tendency has been observed for -1082A and -592A carriers but no signifi cant interaction between time and genotypes for all cognitive domains has been found. 22 Dato et al. (2010) have reported interesting, sex-specifi c associations for cytokine gene polymorphisms in relation to cognitive functioning. IL10-1082GG female carriers have had a signifi cantly lower cognitive functioning compared with AA + AG carriers. Women carrying the C allele (CC + CT) of the IL15 rs2254514 have shown signifi cantly lower cognitive abilities compared with TT carriers. In men, the IL18-137 G carriers (GG + GC) have performed worse on cognitive tests compared with CC carriers. Another important fi nding of this study is the association between the low-producing infl ammatory haplotype IL18-137CC/IL10-1082(AG + GG) and better cognitive functioning, indicating that the balance between pro-infl ammatory and anti-infl ammatory activity of IL-18 and IL-10 loci prevents age-related cognitive decline. 23 
CLINICAL EVIDENCE FOR PARTICIPATION OF CYTOKINE SNPS IN COGNITIVE PROCESSES
Alzheimer's disease (AD) is a neurodegenerative disorder, occupying one of the leading positions among the causes for cognitive decline and dementia in the elderly. Association between cytokine SNPs and the risk for AD represents an indirect evidence for the role of these polymorphisms in cognitive functioning ( Table 2) . In one study, signifi cantly higher frequency of AA variant of IL-10-1082A/G has been found in patients with amnestic mild cognitive impairment who progressed to AD, than that found in patients that remained clinically stable. 24 Two meta-analyses on the role of IL-10-1082 A/G in AD have presented similar results: carriers of A allele, corresponding to lower production of IL-10 had higher risk for the disease than GG homozygotes. 25, 26 These correlations have not been confi rmed for the Asian population, which suggests ethnic variations in the genetic background of cognition. 26 Several SNPs in genes encoding pro-infl ammatory cytokines have been implicated in the risk of developing AD. Studies performed on thousands of patients of different ages, genders, and ethnic origins have shown the T allele of IL-1a-889 C\T and T allele of IL-1b +3953 C/T as strong risk factors for disease development. [27] [28] [29] [30] [31] Moreover, a synergic effect of these SNPs has been found. Homozygosity for both IL-1a-889 TT and IL-1b+3953 TT genotypes has conferred the greatest risk for AD 29, 30 and has been associated with the lowest age of onset. 32 The two most studied SNPs in the promoter 36, 37 As TNF-alpha-308A allele is associated with increased transcription of TNF-alpha 38 , it is supposed that prolonged impact of higher concentrations of this proinfl ammatory cytokine activates glutamatergic excitotoxicity and apoptosis and thus accelerates cortical atrophy. 14 Promoter SNPs, relevant to increased production of another proinfl ammatory cytokine IL-18, have been shown to correlate with the risk for AD. Homozygous carriers of C allele at position-607 in the IL-18 gene have had a higher risk to develop AD. 39 A signifi cant correlation has been reported between the CC variant of this SNP, increased cytokine production and degree of cognitive decline. 40 Similar results have been provided by a study in the Chinese population. C allele at -607IL-18 and G allele at -137IL-18, both individually and as a haplotype (-607C/-137G) have determined a higher risk for occurrence of late onset AD. 41 In addition, homozygous CC genotype of IL-18-137 G/C has been strongly and specifi cally associated with faster progression of cognitive impairment in patients with AD regardless of the presence of the ApoE e4 allele. 39 Association between IL-6−572C/G promoter polymorphism and the risk of developing AD has been found in Chinese population. The −572CC genotype has increased the risk for AD by more than three-fold among the carriers of ApoE e4 allele. 42 Taken together, the data presented above suggest that genetic background predisposing to higher proinfl ammatory and reduced anti-infl ammatory activity increases the risk for cognitive decline.
Parkinson's disease (PD) is another neurodegenerative disorder leading to cognitive impairment in a considerable proportion of the patients. In contrast to the European population, where A allele of IL-10-1082A/G is a risk factor for cognitive defi cit, AA genotype of this polymorphism in Chinese patients with PD has a protective effect against cognitive decline. Homozygous CC variant of IL-17A rs8193036 has increased the risk for cognitive impairment in the same patients' group. 43 44 Cognitive impairments are well recognized in schizophrenia and bipolar disorder (BD). Two studies have investigated the association between cytokine gene polymorphisms and cognitive functioning in these patients. 45 Dickerson et al. (2007) have found a correlation between Repeatable Battery for the Assessment of Neuropsychological Status score and polymorphism in lymphotoxin gene (rs2857713) in schizophrenia but not in BD patients. 46 In a group of 158 schizophrenia patients carriers of +869T allele in TGF-beta gene have shown lower performance on cognitive tests in comparison with +869CC homozygotes. 47 In summary, the majority of the data accumulated to date support the hypothesis that various SNPs in cytokine genes could modify the risk for cognitive impairment in humans. In different conditions they may act as either protective or risk factors for cognitive decline. On the other hand, it has been suggested that polymorphisms do not implement this effect alone but in large interactions between each other, as well as with many other factors, some of which still wait to be identifi ed. Further research is needed to reveal the precise role and the molecular mechanisms of action of the SNPs in cognitive processes. Comprehensive data obtained from large-scale studies on various populations and patients with different diseases should help to identify subgroups at higher risk for cognitive decline requiring close observation. Elucidation of the relationship between SNPs and certain cognitive domain will help for more effective intervention with selective programs for prevention and rehabilitation of cognitive decline.
